Publication | Closed Access

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias

Hematological MalignancyPhiladelphia-positive Acute LeukemiasTransplantationMarrow TransplantationDonor Lymphocyte InfusionsMedicineStem Cell TransplantationImmunologyHematologyCell BiologyBlood TransplantationStem CellsCell TransplantationImatinib MesylateHealth Sciences